Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company's flagship product, the DeScribe Transparent PFD Patch, was FDA 510(k) cleared and CE marked for use in enhancing laser tattoo removal. Clinical trials showed reduced discomfort and faster healing for patients using the patch during tattoo removal procedures.
The patch allows multiple rapid laser passes per session by providing optical clearing of tissue and protecting the epidermis.
Broader applications in dermatology were under development at time of acquisition.
Company acquired by Merz North America in August 2016.
No ongoing independent clinical programs post-acquisition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ON Light Sciences.